Background Multiple sclerosis (MS) commonly affects young adults at the ages 20 to 40
years old, but it can onset at each age. Late-onset multiple sclerosis (LOMS) is defined as …

Multiple sclerosis (MS), an inflammatory demyelinating and neurodegenerative disease of
the central nervous system, usually begins between the ages of 20 and 49 years, though in …

The effect of coronavirus disease (COVID-19) on the risk of relapse in multiple sclerosis
(MS) have been unknown. In this retrospective study of 41 relapsing-remitting MS patients …

The interaction between ageing and multiple sclerosis is complex and carries significant
implications for patient care. Managing multiple sclerosis effectively requires an …

In the majority of cases, multiple sclerosis (MS) is characterized by reversible episodes of
neurological dysfunction, often followed by irreversible clinical disability. Accurate diagnostic …

Background: We conducted this study to estimated the time of conversion from relapsing-
remitting MS (RRMS) to SPMS and its early predictor factors. Methods: In this retrospective …

Being immune privileged, the central nervous system (CNS) is constituted by unique
parenchymal and non-parenchymal tissue-resident macrophages, namely, microglia and …

Objective Older people with multiple sclerosis (MS) have a less active radiological and
clinical presentation, but many still attain significant levels of disability; but what drives …

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that
affects nearly 2.8 million people each year. MS distinguishes three main types: relapsing …

Background Admittedly, little is known about the epidemiological signatures of familial
multiple sclerosis (FMS) in different geographical regions of Iran. Objective To determine the …